ArticleLangenbeck's archives of surgery2026
Treatment of malignant esophageal stricture or esophageal leakage with a Niti-S™ covered anti-reflux stent is safe and efficient.
Article in Langenbeck's archives of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSelf-expanding metal stents (SEMS) are a palliative treatment option for malignant esophageal strictures causing dysphagia. Retrosternal pain, reflux-related symptoms and migration remain relevant limitations. SEMS with an anti-reflux valve (SEMS-ART; Niti-S™ esophageal covered stent, anti-reflux type, TaeWoong Medical) may reduce these limitations but clinical data remain limited. This study evaluates safety, tolerability and clinical performance of SEMS-ART in malignant esophageal stricture and leakage. MATERIALS AND
methodsAll patients treated with SEMS-ART for malignant esophageal stricture or leakage at the Medical University of Vienna, Department of General Surgery, between 01/2016 and 04/2021 were included into this retrospective analysis. Parameters regarding patients' safety, compliance and associated comorbidities like reflux and dysphagia were analyzed.
resultsTwenty patients were included. The cohort was predominantly male (90.0%) with a mean age of 65.3 years. Advanced esophageal cancer UICC stage III-IV was present in 75.0%. Technical success was achieved in all patients (100%). Adequate stent expansion was confirmed in all patients, while correct positioning and normal contrast passage were observed in 95%. Reflux, Dysphagia and Regurgitation resolved in all cases after SEMS insertion (p < 0.001). Dislocation occurred in 15.0% (n = 3) and primarily managed endoscopically. Mean SEMS dwell time was 88.3 days. 30-day SEMS-related safety was 95.0%, and no SEMS-related mortality occurred within the observational period.
conclusionThis small case series demonstrates high technical success of SEMS-ART, supporting feasibility and an acceptable safety profile on migration and symptom relief. These findings support the use of SEMS-ART in selected patients with malignant esophageal stricture and should be considered hypothesis-generating, supporting further prospective comparative studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.